Signal transduction and neurosurvival in experimental models of brain injury

Brain Research Bulletin

Volumn 59, Issue 5, 2003, Pages 339-351

  Butler, T L ^a   Kassed, C A ^a   Pennypacker, K R ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Animal model; AP 1; Growth factor; Neuron; NF B; Signaling pathways

Indexed keywords

GROWTH FACTOR RECEPTOR; TRANSCRIPTION FACTOR;

ALZHEIMER DISEASE; ANIMAL MODEL; BRAIN INJURY; BRAIN ISCHEMIA; CELL DEATH; CELL SURVIVAL; DEGENERATIVE DISEASE; EPILEPSY; HUMAN; HUNTINGTON CHOREA; NERVE CELL; NERVE CELL LESION; NEUROTOXICITY; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; STAINING;

ANIMALS; BRAIN INJURIES; CELL DEATH; GROWTH SUBSTANCES; HUMANS; MODELS, THEORETICAL; NERVE DEGENERATION; NEURONS; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

EID: 0037472348     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0361-9230(02)00926-7     Document Type: Review

References (209)

1. Akins P.T., Liu P.K., Hsu C.Y. Immediate early gene expression in response to cerebral ischemia: Friend or foe? Stroke. 27:1996;1682-1687.
2. Angel P., Karin M. The role of Jun, Fos and the AP-1 complex in cell proliferation and transformation. Biochim. Biophys. Acta. 1072:1991;129-157.
3. Aronowski J., Strong R., Kang H.S., Grotta J.C. Selective up-regulation of I kappaB-alpha in ischemic penumbra following focal cerebral ischemia. Neuroreport. 11:2000;1529-1533.
4. Ashburner B.P., Westerheide S.D., Baldwin A.S.J. The p65 (RelA) subunit of NF-kappa B interacts with the histone deacetylase (HDAC) corepressors HDAC1 and HDAC2 to negatively regulate gene expression. Mol. Cell. Biol. 21:2001;7065-7077.
5. Baeuerle P., Baltimore D. A specific inhibitor of the NFκB. Science. 242:1989;540-546.
6. Bailey C.H., Bartsch D., Kandel E.R. Toward a molecular definition of long-term memory storage. Proc. Natl. Acad. Sci. U.S.A. 93:1996;13445-13452.
7. Baldwin A.S.J. The transcription factor NF-κB and human disease. J. Clin. Invest. 107:2001;3-6.
8. Bamji S.X., Majdan M., Pozniak C.D., Belliveau D.J., Aloyz R., Kohn J., Causing C.G., Miller F.D. The p75 neurotrophin receptor mediates neuronal apoptosis and is essential for naturally occurring sympathetic neuron death. J. Cell Biol. 140:1998;911-923.
9. Banasiak K.J., Cronin T., Haddad G.G. Bcl-2 prolongs neuronal survival during hypoxia-induced apoptosis. Mol. Brain Res. 72:1999;214-225.
10. 2+ accumulation. Proc. Natl. Acad. Sci. U.S.A. 92:1995;9328-9332.
11. Barger S.W., Mattson M.P. Induction of neuroprotective κB-dependent transcription by secreted forms of the Alzheimer's β-amyloid precursor. Mol. Brain Res. 40:1996;116-126.
12. Barkett M., Gilmore T.D. Control of apoptosis by Rel/NF-kappaB transcription factors. Oncogene. 18:1999;6910-6924.
13. Barrett G.L. The p75 neurotrophin receptor and neuronal apoptosis. Prog. Neurobiol. 61:2000;205-229.
14. Bibel M., Hoppe E., Barde Y.-A. Biochemical and functional interactions between the neurotrophin receptors trk and p75NTR. EMBO J. 18:1999;616-622.
15. Boniece I.R., Wagner J.A. Growth factors protect PC12 cells against ischemia by a mechanism that is independent of PKA, PKC, and protein synthesis. J. Neurosci. 13:1993;4220-4228.
16. Bonni A., Brunet A., West A.E., Datta S.R., Takasu M.A., Greenberg M.E. Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms. Science. 286:1999;1358-1362.
17. Borasio G.D., John J., Wittinghofer A., Barde Y.A., Sendtner M., Heumann R. Ras p21 protein promotes survival and fiber outgrowth of cultured embryonic neurons. Neuron. 2:1989;1087-1096.
18. Borlongan C.V., Koutouzis T.K., Jorden J.R., Martinez R., Rodriguez A.I., Poulos S.G., Freeman T.B., McKeown P., Cahill D.W., Nishino H., Sanberg P.R. Neural transplantation as an experimental treatment modality for cerebral ischemia. Neurosci. Behav. Rev. 21:1997;79-90.
19. Boss V., Roback J.D., Young A.N., Roback L.J., Vogt Weisenhorn D.M., Medina-Flores R., Wainer B.H. Nerve growth factor, but not epidermal growth factor, increases Fra-2 expression and alters Fra-2/JunD binding to AP-1 and CREB binding elements in pheochromocytoma (PC12) cells. J. Neurosci. 21:2001;18-26.
20. Brambilla R., Gnesutta N., Minichiello L., White G., Roylance A.J., Herron C.E., Ramsey M., Wolfer D.P., Cestari V., Rossi-Arnaud C., Grant S.G.N., Chapman P.F., Lipp H.-P., Klein R. A role for the Ras signalling pathway in synaptic transmission and long-term memory. Nature. 390:1997;281-286.
21. Bronstein D.M., Ye H., Pennypacker K.R., Hudson P.M., Hong J.S. Role of a 35 kDa fos-related antigen (FRA) in the long-term induction of striatal dynorphin expression in the 6-hydroxydopamine lesioned rat. Mol. Brain Res. 23:1994;191-203.
22. Bruce A.J., Boling W., Kindy M.S., Peschon J., Kraemer P.J., Carpenter M.K., Holtsberg F.W., Mattson M.P. Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors. Nat. Med. 2:1996;788-794.
23. Bruce-Keller A.J., Geddes J.W., Knapp P.E., McFall R.W., Keller J.N., Holtsberg F.W., Perthasarathy S., Steiner S.M., Mattson M.P. Anti-death properties of TNF against metabolic poisoning: Mitochondrial stabilization by MnSOD. J. Neuroimmunol. 93:1999;53-71.
24. Butler T.L., Kassed C.A., Sanberg P.R., Willing A.E., Pennypacker K.R. Neurodegeneration in the rat hippocampus and striatum after middle cerebral artery occlusion. Brain Res. 929:2002;252-260.
25. Cameron H.A., McEwen B.S., Gould E. Regulation of adult neurogenesis by excitatory input and NMDA receptor activation in the dentate gyrus. J. Neurosci. 15:1995;4687-4692.
26. Carrasco D., Bravo R. Tissue-specific expression of the fos-related transcription factor fra-2 during mouse development. Oncogene. 10:1995;1069-1079.
27. Chakraborti T., Kim K.A., Goldstein G.G., Bressler J.P. Increased AP-1 DNA binding activity in PC12 cells treated with lead. J. Neurochem. 73:1999;187-194.
28. Chang L.W., Dyer R.S. A time-course study of trimethyltin induced neuropathology in rats. Neurobehav. Toxicol. Teratol. 5:1983;443-459.
29. Chao M.V. The p75 neurotrophin receptor. J. Neurobiol. 25:1994;1373-1385.
30. Chapman P.F., Falinska A.M., Knevett S.G., Ramsay M.F. Genes, models and Alzheimer's disease. Trends Genet. 17:2001;254-261.
31. Chen C., Edelstein L.C., Gelinas C. The Rel/NF-kappaB family directly activates expression of the apoptosis inhibitor Bcl/x-(L). Mol. Cell. Biol. 20:2000;2687-2695.
32. Chin L., Tam A., Pomerantz J., Wong M., Holash J., Berdeesy N., Shen Q., O'Hagan R., Pantginis J., Zhou H., Horner J.W.I., Cordon-Cardo C., Yancopoulos G.D., DePinho R.A. Essential role for oncogenic Ras in tumour maintenance. Nature. 400:1999;468-472.
33. Choi D.W. Glutamate neurotoxicity and diseases of the nervous system. Neuron. 1:1988;623-634.
34. Choi D.W. Excitotoxic cell death. J. Neurobiol. 23:1992;1261-1276.
35. Choi D.W. Calcium: Still center-stage in hypoxic-ischemic neuronal death. Trends Neurosci. 18:1995;58-60.
36. Chopp M., Chen H., Ho K.L., Dereski M.O., Brown E., Hetzel F.W., Welch K.M. Transient hyperthermia protects against subsquent forebrain ischemic cell damage in the rat. Neurology. 39:1989;1396-1398.
37. Clemens J.A., Stephenson D.T., Smalstig E.B., Dixon E.P., Little S.P. Global ischemia activates nuclear factor-κB in forebrain neurons of rats. Stroke. 28:1997;1073-1081.
38. Clemens J.A., Stephenson D.T., Yin T., Smalstig B., Panetta J.A., Little S.P. Drug-induced neuroprotection from global ischemia is associated with prevention of persistent but not transient activation of nuclear factor-κB in rats. Stroke. 29:1998;677-682.
39. Collazo D., Takahashi H., McKay R.D. Cellular targets and trophic functions of neurotrophin-3 in the developing rat hippocampus. Neuron. 9:1992;643-656.
40. Cook S.J., Aziz N., McMahon M. The repertoire of fos and jun proteins expressed during the G1 phase of the cell cycle is determined by the duration of mitogen-activated protein kinase activation. Mol. Cell. Biol. 19:1999;330-341.
41. Crain B., Westerkam W., Harrison A., Nadler J. Selective neuronal death after transient forebrain ischemia in the Mongolian gerbil: A silver impregnation study. Neuroscience. 27:1988;387-402.
42. Culmsee C., Stumm R.K., Schafer M.K.-H., Weihe E., Krieglstein J. Clenbuterol induces growth factor mRNA, activates astrocytes, and protects rat brain tissue against ischemic damage. Eur. J. Pharmacol. 379:1999;33-45.
43. Davidson C., Gow A.J., Lee T.H., Ellinwood E.H. Methamphetamine neurotoxicity: Necrotic and apoptotic mechanisms and relevance to human abuse and treatment. Brain Res. Rev. 36:2001;1-22.
44. Downward J. Ras signalling and apoptosis. Curr. Opin. Genet. Dev. 8:1998;49-54.
45. Downward J. Signal transduction: New exchange, new target. Nature. 396:1998;416-417.
46. Dragunow M., Beilharz E., Sirimanne E., Lawlor P., Williams C., Bravo R., Gluckman P. Immediate-early gene protein expression in neurons undergoing delayed death, but not necrosis, following hypoxic-ischaemic injury to the young rat brain. Brain Res. 25:1994;19-33.
47. Dragunow M., Preston K. The role of inducible transcription factors in apoptotic nerve cell death. Brain Res. Rev. 21:1995;1-28.
48. Ernfors P., Henschen A., Olson L., Persson H. Expression of nerve growth factor receptor mRNA is developmentally regulated and increased after axotomy in rat spinal cord motoneurons. Neuron. 2:1989;1605-1613.
49. Estus S., Zaks W.J., Freeman R.S., Gruda M., Bravo R., Johnson E.M.J. Altered gene expression in neurons during programmed cell death: Identification of c-jun as necessary for neuronal apoptosis. J. Cell Biol. 127:1994;1717-1727.
50. Estus S., Zaks W.J., Freeman R.S., Gruda M., Bravo R., Johnson E.M.J. Altered gene expression in neurons during programmed cell death: Identification of c-jun as necessary for neuronal apoptosis. J. Cell Biol. 127:1994;1717-1727.
51. Felberg R.A., Okon N.J., El-Mitwalli A., Burgin W.S., Grotta J.C., Alexandrov A.V. Early dramatic recovery during intravenous tissue plasminogen activator fusion: Clinical pattern and outcome in acute middle cerebral artery stroke. Stroke. 33:2002;1301-1307.
52. Finco T.S., Beg A.A., Baldwin A.S. Inducible phosphorylation of I kappa B alpha is not sufficient for its dissociation from NF-kappa B and is inhibited by protease inhibitors. Proc. Natl. Acad. Sci. U.S.A. 91:1994;11884-11888.
53. Fisher M., Meadows M.E., Do T., Weise J., Trubetskoy V., Charette M., Finklestein S.P. Delayed treatment with intravenous basic fibroblast growth factor reduces infarct size following permanent focal cerebral ischemia in rats. J. Cereb. Blood Flow Metab. 15:1995;953-959.
54. Foehr E.D., Lin X., O'Mahony A., Geleziunas R., Bradshaw R.A., Greene W.C. NF-κB signaling promotes both cell survival and neurite process formation in nerve growth factor-stimulated PC12 cells. J. Neurosci. 20:2000. 7556-7563.
55. Frade J.M., Rodriguez-Tebar A., Barde Y.-A. Induction of cell death by endogenous nerve growth factor through its p75 receptor. Nature. 383:1996;166-168.
56. Freyaldenhoven T., Ali S., Schmued L. Systemic administration of MPTP induces thalamic neuronal degeneration in mice. Brain Res. 759:1997;9-17.
57. Friedman W.J., Greene L.A. Neurotrophin signaling via Trks and p75. Exp. Cell Res. 253:1999;131-142.
58. Galter D., Mihm S., Droge W. Distinct effects of glutathione disulfide on the nuclear transcription factors kappa B and the activator protein-1. Eur. J. Biochem. 221:1994;639-648.
59. Gary D.S., Bruce-Keller A.J., Kindy M.S., Mattson M.P. Ischemic and excitotoxic brain injury is enhanced in mice lacking the p55 tumor necrosis factor receptor. J. Cereb. Blood Flow Metab. 18:1998;1283-1287.
60. Gash D.M., Zhang Z., Ovadia A., Cass W.A., Yi A., Simmerman L., Russell D., Martin D., Lapchak P.A., Collins F., Hoffer B.J., Gerhardt G.A. Functional recovery in parkinsonian monkeys treated with GDNF. Nature. 380:1996;252-255.
61. Goss J.R., O'Malley M.E., Zou L., Styren S.D., Kochanek P.M., DeKosky S.T. Astrocytes are the major source of nerve growth factor upregulation following traumatic brain injury in the rat. Exp. Neurol. 149:1998;301-309.
62. Grewel S.S., York R.D., Stork P.J.S. Extracellular-signal-regulated kinase signalling in neurons. Curr. Opin. Neurobiol. 9:1999;544-553.
63. Gruda M., Kovary K., Metz R., Bravo R. Regulation of Fra-1 and Fra-2 phosphorylation differs during the cell cycle of fibroblasts and phosphorylation in vitro by MAP kinase affects DNA binding activity. Oncogene. 9:1994;2537-2547.
64. Guerrini L., Blasi F., Denis-Donini S. Synaptic activation of NF-kappa B by glutamate in cerebellar granule neurons in vitro. Proc. Natl. Acad. Sci. U.S.A. 92:1995;9077-9081.
65. Guha A., Feldkamp M.M., Lau N., Boss G., Pawson A. Proliferation of human malignant astrocytomas is dependent on Ras activation. Oncogene. 15:1997;2755-2765.
66. Guo Q., Robinson N., Mattson M.P. Secreted β-amyloid precursor protein counteracts the proapoptotic action of mutant presenilin-1 by activation of NF-κB and stabilization of calcium homeostatsis. J. Biol. Chem. 273:1998;12341-12351.
67. Hai T., Curran T. Cross-family dimerization of transcription factors Fos/Jun and ATF/CREB alters DNA binding specificity. Proc. Natl. Acad. Sci. U.S.A. 88:1991;3720-3724.
68. Ham J., Babij C., Whitfield J., Pfarr C.M., Lallemand D., Yaniv M., Rubin L.L. A c-Jun dominant negative mutant protects sympathetic neurons against programmed cell death. Neuron. 14:1995;927-939.
69. Hefti F. Pharmacology of neurotrophic factors. Annu. Rev. Pharmacol. Toxicol. 37:1997;239-267.
70. Herdegen T., Leah J.D. Inducible and constitutive transcription factors in the mammalian nervous system: Control of gene expression by Jun, Fos, and Krox, and CREB/ATF proteins. Brain Res. Rev. 28:1998;370-490.
71. Herdegen T., Skene P., Bahr M. The c-Jun transcription factor - Bipotential mediator of neuronal death survival, and regeneration. Trends Neurosci. 20:1997;227-231.
72. Heumann R., Goemans C., Bartsch D., Lingenhohl K., Waldmeier P.C., Hengerer B., Allegrini P.R., Schellander K., Wagner E.F., Arendt T., Kamdem R.H., Obst-Pernberg K., Narz F., Wahle P., Berns H. Transgenic activation of Ras in neurons promotes hypertrophy and protects from lesion-induced degeneration. J. Cell Biol. 151:2000;1537-1548.
73. Hope B.T., Kelz M.B., Duman R.S., Nestler E.J. Chronic electroconvulsive seizure (ECS) treatment results in expression of a long-lasting AP-1 complex in brain with altered composition and characteristics. J. Neurosci. 14:1994;4318-4328.
74. Ikonomidou C., Bittigau P., Ishimaru M.J., Wozniak D.F., Koch C., Genz K., Price M.T., Stefovska V., Horster F., Tenkova T., Dikranian K., Olney J.W. Ethanol-induced apoptotic neurodegeneration and fetal alcohol syndrome. Science. 287:2000;1056-1060.
75. Israel A. The IKK complex: An integrator of all signals that activate NF-κB? Trends Cell Biol. 10:2000;129-133.
76. Jackson G.R., Sampath D., Werrbach-Perez K., Perez-Polo J.R. Effects of nerve growth factor on catalase and glutathione peroxidase in a hydrogen peroxide-resistant pheochromocytoma subclone. Brain Res. 634:1994;69-76.
77. Jantzen P.T., Connor K.E., DiCarlo G., Wenk G.L., Wallace J.L., Rojiani A.M., Coppola D., Morgan D., Gordon M.N. Microglial activation and β-amyloid deposit reduction caused by a nitric oxide-releasing nonsteroidal anti-inflammatory drug in amyloid precursor protein plus presenilin-1 transgenic mice. J. Neurosci. 22:2002;2246-2254.
78. Kaczmarek L. Molecular biology of learning: Is c-fos a new beginning? J. Neurosci. Res. 34:1993;377-381.
79. Kaltschmidt B., Uherek M., Wellmann H., Volk B., Kaltschmidt C. Inhibition of NF-κB potentiates amyloid β-mediated neuronal apoptosis. Proc. Natl. Acad. Sci. U.S.A. 96:1999;9409-9414.
80. Kaltschmidt C., Kaltschmidt B., Baeuerle P.A. Stimulation of ionotropic glutamate receptors activates transcription factor NF-kappa B in primary neurons. Proc. Natl. Acad. Sci. U.S.A. 92:1995;9618-9622.
81. Kaltschmidt C., Kaltschmidt B., Neumann H., Wekerle H., Baeuerle P.A. Constitutive NF-kappa B activity in neurons. Mol. Cell. Biol. 14:1994;3981-3992.
82. Kaminska B., Filipkowski R.K., Zurkowska G., Lason W., Przewlocki R., Kaczmarek L. Dynamic changes in the composition of the AP-1 transcription factor DNA-binding activity in rat brain following Kainate-induced seizures and cell death. Eur. J. Neurosci. 6:1994;1558-1566.
83. Kaminska B., Mosieniak G., Gierdalski M., Kossut M., Kaczmarek L. Elevated AP-1 transcription factor DNA binding activity at the onset of functional plasticity during development of rat sensory cortical areas. Mol. Brain Res. 33:1995;295-304.
84. Kaminska B., Pyrzynska B., Ciechomska I., Wisniewska M. Modulation of the composition of AP-1 complex and its impact on transcriptional activity. Acta Neurobiol. Exp. 60:2000;395-402.
85. Kapinya K., Penzel R., Sommer C., Kiessling M. Temporary changes of the AP-1 transcription factor binding activity in the gerbil hippocampus after transient global ischemia, and ischemic tolerance induction. Brain Res. 872:2000;282-293.
86. Kaplan D.R., Miller F.D. Neurotrophin signal transduction in the nervous system. Curr. Opin. Neurobiol. 10:2000;381-391.
87. Karin M., Liu Z., Zandi E. AP-1 function and regulation. Curr. Opin. Cell Biol. 9:1997;240-246.
88. Kasof G.M., Mandelzys A., Maika S.D., Hammer R.E., Curran T., Morgan J.I. Kainic acid-induced neuronal death is associated with DNA damage and a unique immediate-early gene response in c-fos-lacZ transgenic rats. J. Neurosci. 15:1995;4238-4249.
89. Kassed C.A., Willing A.E., Garbuzova-Davis S., Sanberg P.R., Pennypacker K.R. Lack of NF-κB p50 exacerbates degeneration of hippocampal neurons after chemical exposure and impairs learning. Exp. Neurol. 176:2002;277-288.
90. Kato H., Liu Y., Araki T., Kogure K. Temporal profile of the effects of pretreatment with brief cerebral ischemia on the neuronal damage following secondary ischemic insult in the gerbil: Cumulative damage and protective effects. Brain Res. 553:1991;238-242.
91. Katz M.E., McCormick F. Signal transduction from multiple Ras effectors. Curr. Opin. Genet. Dev. 7:1997;75-79.
92. Kenney A.M., Kocsis J.D. Peripheral axotomy induces long-term c-Jun amino-terminal kinase-1 activation and activator protein-1 binding activity by c-Jun and junD in adult rat dorsal root ganglia in vivo. J. Neurosci. 18:1998;1318-1328.
93. Kermer P., Klocker N., Bahr M. Neuronal death after brain injury. Models, mechanisms, and therapeutic strategies in vivo. Cell Tissue Res. 298:1999;383-395.
94. Kirino T., Tsujita Y., Tamura A. Induced tolerance to ischemia in gerbil hippocampal neurons. J. Cereb. Blood Flow Metab. 11:1991;299-307.
95. Kitagawa K., Matsumoto M., Tagaya M., Kuwabara K., Hata R., Handa N., Fukunaga R., Kimura K., Kamada T. Hyperthermia-induced neuronal protection against ischemic injury in gerbils. J. Cereb. Blood Flow Metab. 11:1991;449-452.
96. Klesse L.J., Meyers K.A., Marshall C.J., Parada L.F. Nerve growth factor induces survival and differentiation through two distinct signaling cascades in PC12 cells. Oncogene. 18:1999;2055-2068.
97. Koh J.-Y., Gwag B.J., Lobner D., Choi D.W. Potentiated necrosis of cultured cortical neurons by neurotrophins. Science. 268:1995;573-575.
98. Koistinaho J., Hokfelt T. Altered gene expression in brain ischemia. Neuroreport. 8:1997;i-viii.
99. Kokaia Z., Nawa H., Uchino H., Elmer E., Kokaia M., Carnahan J., Smith M.-L., Siesjo B.K., Lindvall O. Regional brain-derived neurotrophic factor mRNA and protein levels following transient forebrain ischemia in the rat. Mol. Brain Res. 38:1996;139-144.
100. Kovacs A.D., Cebers G., Liljequist S. Prolonged enhancement of AP-1 DNA binding by blockade of glutamate uptake in cultured neurons. Neuroreport. 10:1999;1805-1809.
101. Kovary K., Bravo R. Expression of different Jun and Fos proteins during the G0-to-G1 transition in mouse fibroblasts: In vitro and in vivo associations. Mol. Cell. Biol. 11:1991;2451-2459.
102. Kunsch C., Ruben S.M., Rosen C.A. Selection of optimal kappa B/Rel DNA-binding motifs: Interaction of both subunits of NF-kappa B with DNA is required for transcriptional activation. Mol. Cell. Biol. 12:1992;4412-4421.
103. Lafon-Cazal M., Pietri S., Culcasi M., Bockaert J. NMDA-dependent superoxide production and neurotoxicity. Nature. 364:1993;535-537.
104. Laurer H.L., McIntosh T.K. Experimental models of brain trauma. Curr. Opin. Neurol. 12:1999;715-721.
105. Lewen A., Fujimura M., Sugawara T., Matz P., Copin J.-C., Chan P.H. Oxidative stress-dependent release of mitochondrial cytochrome c after traumatic brain injury. J. Cereb. Blood Flow Metab. 21:2001;914-920.
106. Lewin G.R., Barde Y.A. Physiology of the neurotrophins. Annu. Rev. Neurosci. 19:1996;289-317.
107. Lewin G.R., Ritter A.M., Mendell L.M. Nerve growth factor-induced hyperalgesia in the neonatal and adult rat. J. Neurosci. 13:1993;2136-2148.
108. Li Y., Chopp M., Zhang Z.G., Zhang R.L., Garcia J.H. Neuronal survival is associated with 72-kDa heat shock protein expression after transient middle cerebral artery occlusion in the rat. J. Neurol. Sci. 120:1993;187-194.
109. Lipton P. Ischemic cell death in brain neurons. Physiol. Rev. 79:1999;1431-1568.
110. Lipton S.A. Janus faces of NF-κB: Neurodestruction versus neuroprotection. Nat. Med. 3:1997;20-22.
111. Liu J., Solway K., Messing R.O., Sharp F.R. Increased neurogenesis in the dentate gyrus after transient global ischemia in gerbils. J. Neurosci. 18:1998;7768-7778.
112. Liu Y.-Z., Boxer L.M., Latchman D.S. Activation of the Bcl-2 promoter by nerve growth factor is mediated by the p42/p44 MAPK cascade. Nucleic Acids Res. 27:1999;2086-2090.
113. Longa Z.E., Weinstein P.R., Carlson S., Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke. 20:1989;84-91.
114. Luhmann H.J. Ischemia and lesion induced imbalances in cortical function. Prog. Neurobiol. 48:1996;131-166.
115. Lynch G., Gall C., Rose G., Cotman C. Changes in distribution of the dentate gyrus associational system following unilateral or bilateral entorhinal lesions in the adult rat. Brain Res. 110:1976;57-71.
116. Maggirwar S.B., Sarmiere P.D., Dewhurst S., Freeman R.S. Nerve growth factor-dependent activation of NF-κB contributes to survival of sympathetic neurons. J. Neurosci. 18:1998;10356-10365.
117. Martin D., Miller G., Rosendahl M., Russell D.A. Potent inhibitory effects of glial derived neurotrophic factor against kainic acid mediated seizures in the rat. Brain Res. 683:1995;172-178.
118. Martin L.J., Al-Abdulla N.A., Brambrink A.M., Kirsch J.R., Sieber F., Portera-Cailliau C. Neurodegeneration in excitotoxicity, global cerebral ischemia, and target deprivation: A perspective on the contributions of apoptosis and necrosis. Brain Res. Bull. 46:1998;281-309.
119. Martinez J.L., Derrick B.E. Long-term potentiation and learning. Annu. Rev. Psychol. 47:1996;173-203.
120. Martinou J.-C., Dubois-Dauphin M., Staple J.K., Rodriguez I., Frankowski H., Missotten M., Albertini P., Talabot D., Catsicas S., Pietra C., Huarte J. Overexpression of BCL-2 in transgenic mice protects neurons from naturally occurring cell death and experimental ischemia. Neuron. 13:1994;1017-1030.
121. Masliah E., Westland C.E., Rockenstein E.M., Abraham C.R., Mallory M., Veinberg I., Sheldon E., Mucke L. Amyloid precursor proteins protect neurons of transgenic mice against acute and chronic excitotoxic injuries in vivo. Neuroscience. 78:1997;135-146.
122. Mattson M.P. Calcium and neuronal injury in Alzheimer's disease. Contributions of β-amyloid precursor protein mismetabolism, free radicals, and metabolic compromise. Ann. N.Y. Acad. Sci. 747:1994;50-76.
123. Mattson M.P. Neuroprotective signal transduction: Relevance to stroke. Neurosci. Biobehav. Rev. 21:1997;193-206.
124. Mattson M.P., Culmsee C., Yu Z., Camandola S. Roles of nuclear factor κB in neuronal survival and plasticity. J. Neurochem. 74:2000;443-456.
125. Mattson M.P., Goodman Y., Luo H., Fu W., Furukawa K. Activation of NF-kappa B protects hippocampal neurons against oxidative stress-induced apoptosis: Evidence for induction of manganese superoxide dismutase and suppression of peroxynitrite production and protein tyrosine nitration. J. Neurosci. Res. 49:1997;681-697.
126. Mattson M.P., Kumar K.N., Wang H., Cheng B., Michaelis E.K. Basis FGF regulates the expression of a functional 71 kDa NMDA receptor protein that mediates calcium influx and neurotoxicity in hippocampal neurons. J. Neurosci. 13:1993;4575-4588.
127. 2+ oncentration, and neurotoxicity and increase antioxidant enzyme activities in hippocampal neurons. J. Neurochem. 65:1995;1740-1751.
128. McKay R. Stem cells in the central nervous system. Science. 276:1997;66-71.
129. Metz R., Bannister A.J., Sutherland J.A., Hagemeier C., O'Rourke E.C., Cook A., Bravo R., Kouzarides T. c-Fos-induced activation of a TATA-box-containing promoter involves direct contact with TATA-box-binding protein. Mol. Cell. Biol. 14:1994;6021-6029.
130. Meyer R., Hatada E.N., Hohmann H., Haiker M., Bartsch C., Rothlisberger U., Lahm H., Schlaeger E.J., Van loon A.P.G.M., Scheidereit C. Cloning of the DNA-binding subunit of human nuclear factor κB: The levels of its mRNA is strongly regulated by phorbol ester or tumor necrosis factor-alpha. Proc. Natl. Acad. Sci. U.S.A. 88:1991;966-970.
131. Miller R.G., Petajan J.H., Bryan W.W., Armon C., Barohn R.J., Goodpasture J.C., Hoagland R.J., Parry G.J., Ross M.A., Stromatt S.C. A placbo-controlled trial of recombinant human ciliary neurotrophic (rhCNTF) factor in amyotrophic lateral sclerosis. Ann. Neurol. 39:1996;256-260.
132. Morgan J.I., Cohen D.R., Hempstead J.L., Curran T. Mapping patterns of c-fos expression in the central nervous system after seizure. Science. 237:1987;192-197.
133. Murakami K., Kondo T., Kawase M., Li Y., Sato S., Chen S.F., Chan P.H. Mitochondrial susceptibility to oxidative stress exacerbates cerebral infarction that follows permanent focal cerebral ischemia in mutant mice with manganese superoxide dismutase deficiency. J. Neurosci. 18:1998;3659-3668.
134. Nicole O., Ali C., Docagne F., Plawinski L., MacKenzie E.T., Vivien D., Buisson A. Neuroprotection mediated by glial cell line-derived neurotrophic factor: Involvement of a reduction of NMDA-induced calcium influx by the mitogen-activated protein kinase pathway. J. Neurosci. 21:2001;3024-3033.
135. Nishina H., Sato H., Suzuki T., Sato M., Iba H. Isolation and characterization of fra-2, an additional member of the fos gene family. Proc. Natl. Acad. Sci. U.S.A. 87:1990;3619-3623.
136. Nistico G., Ciriolo M.R., Fiskin K., Iannone M., De Martino A., Rotilio G. NGF restores decrease in catalase activity and increases superoxide dismutase and glutathione peroxidase activity in the brain of aged rats. Free Radic. Biol. Med. 12:1992;177-181.
137. O'Callaghan J.P., Miller D.B. Neurotoxicity profiles of substituted amphetamines in the C57BL/6J mouse. J. Pharmacol. Exp. Ther. 270:1994;741-751.
138. O'Neill L.A.J., Kaltschmidt C. NF-κB: A crucial transcription factor for glial and neuronal cell function. Trends Neurosci. 20:1997;252-258.
139. Orban P.C., Chapman P.F., Brambilla R. Is the Ras-MAPK signalling pathway necessary for long-term memory formation? Trends Neurosci. 22:1999;38-44.
140. Patapoutian A., Reichardt L.F. Trk receptors: Mediators of neurotrophin action. Curr. Opin. Neurobiol. 11:2001;272-280.
141. Pennypacker K.R., Eidizadeh S., Kassed C.A., O'Callaghan J.P., Sanberg P.R., Willing A.E. Expression of fos-related antigen-2 in rat hippocampus after middle cerebral arterial occlusion. Neurosci. Lett. 289:2000;1-4.
142. Pennypacker K.R., Hong J.-S., McMillian M.K. Implications of prolonged expression of Fos-related antigens. Trends Pharmacol. Sci. 16:1995;317-321.
143. Pennypacker K.R., Kassed C.A., Eidizadeh S., Saporta S., Sanberg P.R., Willing A.E. NF-κB p50 is increased in neurons surviving hippocampal injury. Exp. Neurol. 172:2001;307-319.
144. Pennypacker K.R., McMillian M.K., Douglass J., Hong J.S. Ontogeny of kainate-induced gene expression in rat hippocampus. J. Neurochem. 62:1994;438-444.
145. Pennypacker K.R., Walczak D., Thai L., Fannin R., Mason E., Douglass J., Hong J.S. Kainate-induced changes in opioid peptide genes and AP-1 protein expression in the rat hippocampus. J. Neurochem. 60:1993;204-211.
146. Pennypacker K.R., Yang X., Gordon M.N., Benkovic S., Miller D., O'Callaghan J.P. Long-term induction of Fos-related antigen-2 after methamphetamine-, methylenedioxymethamphetamine-, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine- and trimethyltin-induced brain injury. Neuroscience. 101:2000;913-919.
147. Pennypacker K.R., Zhang W.Q., Ye H., Hong J.S. Apomorphine induction of AP-1 DNA binding in the rat striatum after dopamine depletion. Mol. Brain Res. 15:1992;151-155.
148. Perez-Pinzon M.A., Alonso O., Kraydieh S., Dietrich W.D. Induction of tolerance against traumatic brain injury by ischemic preconditioning. Neuroreport. 10:1999;2951-2954.
149. Petty B.G., Cornblath D.R., Adornato B.T., Chaudhry V., Flexner C., Wachsman M., Sinicropi D., Burton L.E., Peroutka S.J. The effect of systemically administered recombinant human nerve growth factor in healthy human subjects. Ann. Neurol. 36:1994;244-246.
150. Philbert M.A., Billingsley M.L., Reufil K.R. Mechanisms of injury in the central nervous system. Toxicol. Pathol. 28:2000;43-53.
151. Pimentel B., Sanz C., Varela-Nieto I., Rapp U.R., De Pablo F., de La Rosa E.J. c-Raf regulates cell survival and retinal ganglion cell morphogenesis during neurogenesis. J. Neurosci. 20:2000;3254-3262.
152. Prasad A.V., Pilcher W.H., Joseph S.A. Nuclear factor-κB in rat brain: Enhanced DNA-binding activity following convulsant-induced seizures. Neurosci. Lett. 170:1994;145-148.
153. Price D.L., Sisodia S.S., Borchelt D.R. Genetic neurodegenerative diseases: The human illness and transgenic models. Science. 282:1998;1079-1083.
154. Putcha G.V., Deshmukh M., Johnson E.M.J. BAX translocation is a critical event in neuronal apoptosis: Regulation by neuroprotectants, BCL-2, and caspases. J. Neurosci. 19:1999;7476-7485.
155. Qin Z.H., Wang Y., Nakai M., Chase T.N. Nuclear factor-kappa B contributes to excitotoxin-induced apoptosis in rat striatum. Mol. Pharmacol. 53:1998;33-42.
156. Quitsche W.W., Goldgaber D. The amyloid beta-protein precursor promoter. A region essential for transcription activity contains a nuclear factor binding protein. J. Biol. Chem. 267:1992;17362-17368.
157. Rabizadeh S., Oh J., Zhong L., Yang J., Bitler C.M., Butcher L.L., Bredesen D.E. Induction of apoptosis by the low-affinity NGF receptor. Science. 261:1993;345-348.
158. Rezzonico R., Loubat A., Lallemand D., Pfarr C.M., Far D.F., Proudfoot A., Rossi B., Ponzio G. Cyclic AMP stimulates a JunD/Fra-2 AP-1 complex and inhibits the proliferation of interleukin-6-dependent cell lines. Oncogene. 11:1995;1069-1078.
159. Robertson G.S., Herrera D.G., Dragunow M., Robertson H.A. l-DOPA activates c-fos in the striatum ipsilateral to a 6-hydroxydopamine lesion of the substantia nigra. Eur. J. Pharmacol. 150:1991;99-100.
160. Robinson G.A. Changes in the expression of transcription factors ATF-2 and FRA-2 after axotomy and during regeneration in rat retinal ganglion cells. Mol. Brain Res. 41:1996;57-64.
161. Rong Y., Baudry M. Seizure activity results in a rapid induction of nuclear factor-kappa B in adult but not juvenile rat limbic structures. J. Neurochem. 67:1996;662-668.
162. Rosen J.B., Chuang E., Iadarola M.J. Differential induction of Fos protein and a Fos-related antigen following acute and repeated cocaine administration. Mol. Brain Res. 25:1994;168-172.
163. Roux P.P., Colicos M.A., Barker P.A., Kennedy T.E. p75 neurotrophin receptor expression is induced in apoptotic neurons after seizure. J. Neurosci. 19:1999;6887-6896.
164. Saccani S., Pantano S., Natoli G. Two waves of nuclear factor kappa B recruitment to target promoters. J. Exp. Med. 193:2001;1351-1359.
165. Saille C., Marin P., Martinou J.C., Nicole A., London J., Ceballos-Picot I. Transgenic murine cortical neurons expressing human Bcl-2 exhibit increased resistance to amyloid beta-peptide neurotoxicity. Neuroscience. 92:1999;1455-1463.
166. Scheid M.P., Duronio V. Dissociation of cytokine-induced phosphorylation of Bad and activation of PKB/akt: Involvement of MEK upstream of Bad phosphorylation. Proc. Natl. Acad. Sci. U.S.A. 95:1998;7439-7444.
167. Schenk H., Klein M., Erdbrugger W., Droge W., Schulze-Osthoff K. Distinct effects of thioredoxin and antioxidants on the activation of NF-kappa B and AP-1. Proc. Natl. Acad. Sci. U.S.A. 91:1993;1672-1676.
168. Schmidt-Kastner R., Freund T.F. Selective vulnerability of the hippocampus in brain ischemia. Neuroscience. 40:1991;599-636.
169. Schmidt-Ullrich R., Memet S., Lilienbaum A., Feuillard J., Raphael M., Israel A. NF-κB activity in transgenic mice: Developmental regulation and tissue specificity. Development. 122:1996;2117-2128.
170. Schmued L.C., Albertson C., Slikker W.J. Fluoro-Jade: A novel fluorochrome for the sensitive and reliable histochemical localization of neuronal degeneration. Brain Res. 751:1997;37-46.
171. Schmued L.C., Hopkins K.J. Fluoro-Jade: Novel fluorochromes for detecting toxicant-induced neuronal degeneration. Toxicol. Pathol. 28:2000;91-99.
172. Schneider A., Martin-Villalba A., Weih F., Vogel J., Wirth T., Schwaninger M. NF-κB is activated and promotes cell death in focal cerebral ischemia. Nat. Med. 5:1999;554-559.
173. Sen C.K., Packer L. Antioxidant and redox regulation of gene transcription. FASEB J. 10:1996;709-720.
174. Sharp A.H., Ross C.A. Neurobiology of Huntington's disease. Neurobiol. Dis. 3:1996;3-15.
175. Sharp F.R., Lu A., Tang Y., Millhorn D.E. Multiple molecular penumbras after focal cerebral ischemia. J. Cereb. Blood Flow Metab. 20:2000;1011-1032.
176. Sinn E., Muller W., Pattengale P., Tepler I., Wallace R., Leder P. Coexpression of MMTV/v-Ha-ras and MMTV/c-myc genes in transgenic mice: Synergistic action of oncogenes in vivo. Cell. 49:1987;465-475.
177. Smeyne R.J., Vendrell M., Hayward M., Baker S.J., Miao G.G., Schilling K., Robertson L.M., Curran T., Morgan J.I. Continuous c-fos expression precedes programmed cell death in vivo. Nature. 363:1993;166-169.
178. Smith-Swintosky V.L., Pettigrew L.C., Craddock S.D., Culwell A.R., Rydel R.E., Mattson M.P. Secreted forms of beta-amyloid precursor protein protect against ischemic brain injury. J. Neurochem. 63:1994;781-784.
179. Soares H.D., Chen S.-C., Morgan J.I. Differential and prolonged expression of Fos-lacZ and Jun-lacZ in neurons, glia, and muscle following sciatic nerve damage. Exp. Neurol. 167:2001;1-14.
180. Sonnenberg J.L., Macgregor-Leon P.F., Curran T., Morgan J.I. Dynamic alterations occur in the levels and composition of transcription factor AP-1 complexes after seizure. Neuron. 3:1989;359-365.
181. Stancovski I., Baltimore D. NF-κB activation: The IkB kinase revealed. Cell. 91:1997;299-302.
182. Stein B., Baldwin A.S.J., Ballard D.W., Greene W.C., Angel P., Herrlich P. Cross-coupling of the NF-κB p65 and Fos/Jun transcription factors produces potentiated biological function. EMBO J. 12:1993;3879-3891.
183. Suzuki T., Okuno H., Yoshida T., Endo T., Nishina H., Iba H. Difference in transcriptional regulatory function between c-Fos and Fra-2. Nucleic Acids Res. 19:1991;5537-5542.
184. Switzer R.C.R. Application of silver degeneration stains for neurotoxicity testing. Toxicol. Pathol. 28:2000;70-83.
185. Tamura A., Graham D.I., McCulloch J., Teasdale G.M. Focal cerebral ischaemia in the rat: 1. Description of technique and early neuropathological consequences following middle cerebral artery occlusion. J. Cereb. Blood Flow Metab. 1:1981;53-60.
186. Tirassa P., Aloe L., Stenfors C., Turrini P., Lundeberg T. Cholecystokinin-8 protects central cholinergic neurons against fimbria-fornix lesion through the up-regulation of nerve growth factor synthesis. Proc. Natl. Acad. Sci. U.S.A. 96:1999;6473-6477.
187. Traenckner E.B., Baeuerle P.A. Appearance of apparently ubiquitin-conjugated I kappa B-alpha during its phosphorylation-induced degradation in intact cells. J. Cell Sci. 19:1995;79-84.
188. Urban M.B., Baeuerle P.A. The role of the p50 and p65 subunits of NF-kappa B in the recognition of cognate sequences. New Biol. 3:1991;279-288.
189. Urban M.B., Schreck R., Baeuerle P.A. NF-kappa B contacts DNA by a heterodimer of the p50 and p65 subunit. EMBO J. 10:1991;1817-1825.
190. van Praag H., Schinder A.F., Christie B.R., Toni N., Palmer T.D., Gage F.H. Functional neurogenesis in the adult hippocampus. Nature. 415:2002;1030-1034.
191. Virolle T., Monthouel M.N., Djabari Z., Ortonne J.P., Meneguzzi G., Aberdam D. Three activator protein-1-binding sites bound by the Fra-2. JunD complex cooperate for the regulation of murine laminin alpha3A (lama3A) promoter activity by transforming growth factor-beta. J. Biol. Chem. 273:1998;17318-17325.
192. Volkert M., Wagner M., Peters C., Waldmann H. The chemical biology of Ras lipidation. Biol. Chem. 382:2001;1133-1145.
193. Wang C.Y., Guttridge D.C., Mayo M.W., Baldwin A.S.J. NF-kappa B induces expression of the Bcl-2 homologue A1/Bfl-1 to preferentially suppress chemotherapy-induced apoptosis. Mol. Cell. Biol. 19:1999;5923-5929.
194. Wang C.Y., Mayo M.W., Korneluk R.G., Goeddel D.V., Baldwin A.S.J. NF-kappa B antiapoptosis: Induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science. 281:1998;1680-1683.
195. Weiller C., Chollet F., Friston K.J., Wise R.J.S., Frackowiak R.S.J. Functional reorganization of the brain in recovery from striatocapsular infarction in man. Ann. Neurol. 31:1992;463-472.
196. Whitfield P.C., Williams R., Pickard J.D. Delayed induction of JunB precedes CA1 neuronal death after global ischemia in the gerbil. Brain Res. 818:1999;450-458.
197. Williams E.J., Doherty P. Evidence for and against a pivotal role of PI 3-kinase in a neuronal cell survival pathway. Mol. Cell. Neurosci. 13:1999;272-280.
198. Xia Z., Dickens M., Raingeaud J., Davis R.J., Greenberg M.E. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science. 270:1995;1326-1331.
199. Xiao Y., Harry G.J., Pennypacker K.R. Expression of AP-1 transcription factors in rat hippocampus and cerebellum after trimethyltin neurotoxicity. Neurotoxicology. 20:1999;761-766.
200. Xue L., Murray J.H., Tolkovsky A.M. The Ras/phosphatidylinositol 3-kinase and Ras/ERK pathways function as independent survival modules each of which inhibits a distinct apoptotic signaling pathway in sympathetic neurons. J. Biol. Chem. 275:2000;8817-8824.
201. Yamada K., Kinoshita A., Kohmura E., Sakaguchi T., Taguchi J., Kataoka K., Hayakawa T. Basic fibroblast growth factor prevents thalamic degeneration after cortical infarction. J. Cereb. Blood Flow Metab. 11:1991;472-478.
202. Yang G., Kitagawa K., Ohtsuki T., Kuwabara K., Mabuchi T., Yagita Y., Takazawa K., Tanaka S., Yanagihara T., Hori M., Matsumoto M. Regional difference of neuronal vulnerability in the murine hippocampus after transient forebrain ischemia. Brain Res. 870:2000;195-198.
203. Yang K., Mu Y.S., Hayes R.L. Increased cortical nuclear factor-κB (NF-κB) DNA binding activity after traumatic brain injury in rats. Neurosci. Lett. 197:1995;101-104.
204. Yeo T.T., Chua-Couzens J., Butcher L.L., Bredesen D.E., Cooper J.D., Valletta J.S., Mobley W.C., Longo F.M. Absence of p75NTR causes increased basal forebrain cholinergic neuron size, choline acetyltransferase activity, and target innervation. J. Neurosci. 17:1997;7594-7605.
205. Yoneda Y., Ogita K., Inoue K., Mitani A., Zhang L., Masuda S., Higashihara M., Kataoka K. Rapid potentiation of DNA binding activities of particular transcription factors with leucine-zipper motifs in discrete brain structures of the gerbil with transient forebrain ischemia. Brain Res. 667:1994;54-66.
206. Yu Z., Zhou D., Bruce-Keller A.J., Kindy M.S., Mattson M.P. Lack of the p50 subunit of nuclear factor-κB increases the vulnerability of hippocampal neurons to excitotoxic injury. J. Neurosci. 19:1999;8856-8865.
207. Yuen E.C., Mobley W.C. Therapeutic potential of neurotrophic factors for neurological disorders. Ann. Neurol. 40:1996;346-354.
208. Zaczek R., Simonton S., Coyle J.T. Local and distant neuronal degeneration following intrastriatal injection of kainic acid. J. Neuropathol. Exp. Neurol. 39:1980;245-264.
209. Zandi E., Chen Y., Karin M. Direct phosphorylation of IkB by IKKα and IKKβ: Discrimination between free and NF-κB-bound substrate. Science. 281:1998;1360-1363.